HBPCF (Helix BioPharma) General and Admin. Expense: $1.21 Mil (TTM As of Apr. 2026)

What is Helix BioPharma General and Admin. Expense?

Helix BioPharma HBPCF 28 General and Admin. Expense is $1.21 Mil as of Apr. 2026. GuruFocus rates HBPCF with a GF Score™ of 28/100.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Helix BioPharma's General and Admin. Expense for the three months ended in Apr. 2026 was $0.29 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Apr. 2026 was $1.21 Mil.

Helix BioPharma General and Admin. Expense Related Terms

Helix BioPharma General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Helix BioPharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix BioPharma General and Admin. Expense Chart

Helix BioPharma Annual Data

Trend

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Jul25

General and Admin. Expense

Get a 7-Day Free Trial

2.59

1.16

0.79

2.38

1.34

Helix BioPharma Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
General and Admin. Expense	Get a 7-Day Free Trial															0.46	0.35	0.38	0.19	0.29

28GF Score

Helix BioPharma Corp HBPCF

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Helix BioPharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.21 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of $1.21 Mil mean?

Helix BioPharma (HBPCF) has a General and Admin. Expense of $1.21 Mil as of Apr. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Helix BioPharma and its competitors.

Is Helix BioPharma's General and Admin. Expense too high?

Helix BioPharma's current General and Admin. Expense is $1.21 Mil. Overall, Helix BioPharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Helix BioPharma's General and Admin. Expense compare to VRTX and REGN?

Helix BioPharma's General and Admin. Expense of $1.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Helix BioPharma and its competitors. Helix BioPharma's current General and Admin. Expense is $1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Helix BioPharma stock overvalued right now?

Helix BioPharma (HBPCF) has a current General and Admin. Expense of $1.21 Mil. The current General and Admin. Expense is $1.21 Mil. Helix BioPharma's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For Helix BioPharma (HBPCF), the current General and Admin. Expense is $1.21 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix BioPharma Business Description

Industry Healthcare Biotechnology

Comparable Companies TSXV:EBM TSXV:ARCH XCNQ:TELI XCNQ:METX TSX:SVA TSXV:NRX TSXV:MIR NEOE:ONCO TSX:MBX XCNQ:DTC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges HBP0:Germany HBP:Canada

Address 40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4

Website https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company developing therapies in immune-oncology focused on cancer prevention and treatment. The Company is developing a proprietary platform of bio-conjugates targeting hard-to-treat solid tumors over-expressing CEACAM6, including Tumor Defense Breaker, L-DOS47, and three CEACAM6-specific antibody-drug conjugates. Its pre-IND candidates include LEUMUNA, an oral immune checkpoint modulator for hematological malignancies, and GEMCEDA, an oral prodrug of gemcitabine for solid tumors.

28GF Score

Get the complete analysis for HBPCF

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.71

Price

View HBPCF Analysis

See General and Admin. Expense data for all stocks →